BioSpace News Archive

MDxHealth SA, a commercial-stage precision diagnostics company, announced its financial results for the second quarter and half year ended June 30, 2023.

RVL Pharmaceuticals plc (Nasdaq: RVLP) (“RVL” or the “Company”), a specialty pharmaceutical company, today announced that Brian Markison, Chief Executive Officer, will participate in a fireside chat and host 1x1 investor meetings at the H.C. Wainwright 25th Annual Global Investment Conference in New York City.

Mirati Therapeutics, Inc.®, a commercial stage biotechnology company, announced that Laurie Stelzer, Chief Financial Officer, will depart the company on September 8, 2023, to pursue an external opportunity.

Gilead Sciences, Inc. announced that its executives will be speaking at the following investor conferences.

REGENXBIO Inc. (Nasdaq: RGNX) today announced presentations at the Society for the Study of Inborn Errors of Metabolism Annual Symposium 2023 in Jerusalem, Israel (August 29 – September 1).

BD, a leading global medical technology company, announced that it will present at the following healthcare conferences.

Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced plans to release its financial results for the second quarter ended June 30, 2023 on Friday, August 25, 2023.

CVS Health® announced that it has launched Cordavis, a wholly owned subsidiary that will work directly with manufacturers to commercialize and/or co-produce biosimilar products for the U.S. pharmaceutical market.

APRINOIA Therapeutics announced a mutual termination of its previously announced business combination agreement with Ross Acquisition Corp II, a special purpose acquisition company.

Samsung Biologics, a global contract development and manufacturing organization, announced the appointments of Gail Ward as Executive Vice President and Head of the Quality Center, and Sojeong Lee as Vice President and Head of Regulatory Affairs.